CV | Twitter | LinkedIn | ResearchGate | ORCID | Operation Naloxone


Lucas Hill graduated from the UMKC School of Pharmacy and completed a residency in the UPMC Department of Family Medicine. He is now a clinical assistant professor of health outcomes and pharmacy practice at The University of Texas at Austin College of Pharmacy. Dr. Hill precepts learners and cares for patients with complex chronic disease at the CommUnityCare FQHCs. He is Director of Operation Naloxone and Principal Investigator of the Texas Targeted Opioid Response: Overdose Prevention Project.

Media & Publications

Spectrum News | In Focus: The Medication Used to Treat Overdoses

Alcalde | How Texas is Trying to Stay Ahead of the Opioid Epidemic

Jordan RP, Bratberg J, Congdon HB, Cross LB, Hill LG, et al. The report of the 2016-2017 advocacy standing committee. Am J Pharm Educ. 2017;81(8):S10.

iForumRx | Painstaking Efforts to Improve Opioid Stewardship (iTunes / PodBean)

Han JK, Hill LG, Koenig ME, Das N. Naloxone Counseling for Harm Reduction and Patient Engagement. Fam Med. 2017;49(9):730-3.

UT News | This is Why the Opioid Crisis is as Dangerous as a Terrorist Attack

The Utopian | Minimizing Harm

NPR Marketplace | Overdose Prevention on College Campuses

Corbo JM, Delellis TM, Hill LG, Rindfuss SL. ACE inhibitors or ARBs to prevent CKD in patients with microalbuminuriaAm Fam Physician. 2016;94(8):652-3.

iForumRx | Coprescribing Naloxone: A Moral Imperative (iTunes / PodBean)

iForumRx | Opioid Safety & Overdose Prevention Resource Page

The Daily Texan | College of Pharmacy Combats Opioid Overdose with Campus Campaign

2409 University Avenue | A1910, PHR 2.222G | Austin, TX 78712 | 512.232.7832 |